A Morgan Stanley analyst identifies the point where investors might find an attractive entry point to get back in the market.
Smartleaf Asset Management LLC lifted its stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 37.2% during the fourth quarter, HoldingsChannel.com reports. The firm owned 538 shares ...